Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 1/2 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Leukemia, Myeloid, Acute 81Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Myelodysplastic Syndromes 22Recurrence 13Congenital Abnormalities 12Lymphoma, Non-Hodgkin 9Leukemia, Biphenotypic, Acute 9Burkitt Lymphoma 9Lymphoma, Mantle-Cell 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Monocytic, Acute 7Hodgkin Disease 7Lymphoma 6Leukemia, Myelomonocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Myeloproliferative Disorders 4Lymphoma, Follicular 4Lymphoma, B-Cell 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Leukemia, Prolymphocytic 3Leukemia, Myeloid 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Blast Crisis 3

Interventions

venetoclax 5Dexamethasone 5Cytarabine 3Cyclophosphamide 3Vincristine 2Decitabine 2trametinib 1ruxolitinib 1pegaspargase 1nilotinib 1navitoclax 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1capivasertib 1blinatumomab 1Vorinostat 1Spinal Puncture 1Specimen Handling 1Mitoxantrone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Dasatinib 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Cytarabine × Clear all
NCT05658640 2025-09-16

HEM-iSMART D

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
26 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05745714 2025-09-16

HEM-iSMART C

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
26 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05751044 2025-09-16

HEM-iSMART B

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
26 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡